Literature DB >> 15786581

Interim UK guidelines for management of close community contacts of invasive group A streptococcal disease.

.   

Abstract

Group A streptococci cause a wide range of illnesses from non-invasive disease such as pharyngitis to more severe invasive infections such as necrotising fasciitis. There remains uncertainty about the risk of invasive disease among close contacts of an index case of invasive disease and whether this risk warrants antibiotic prophylaxis. A 19-200 fold increased risk among household contacts has been reported in the literature. Recommendations for antibiotic prophylaxis regimens vary by country. A comprehensive literature review together with preliminary analysis of 2003 United Kingdom data from the strep-EURO programme informed the interim recommendations of an expert working group. The evidence base to formulate definitive guidance is weak. Risk calculations based on provisional UK data estimated that over 2,000 contacts would need to receive antibiotic prophylaxis to prevent a subsequent case of invasive group A streptococcal disease. The Working Group considered that currently available evidence did not warrant the routine administration of chemoprophylaxis to all close community contacts. More robust risk estimates will be derived from ongoing UK surveillance data to inform a review of this guidance in 2005.

Entities:  

Mesh:

Year:  2004        PMID: 15786581

Source DB:  PubMed          Journal:  Commun Dis Public Health        ISSN: 1462-1843


  23 in total

1.  Invasive group A streptococcal disease: Management and chemoprophylaxis.

Authors:  Ud Allen; Dl Moore
Journal:  Paediatr Child Health       Date:  2010-05       Impact factor: 2.253

2.  Recent advances in the treatment of necrotizing fasciitis.

Authors:  Marina S Morgan
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

3.  Invasive group A streptococcal disease: Management and chemoprophylaxis.

Authors:  Ud Allen; Dl Moore
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  First reported cluster of overwhelming group A streptococcal septicaemia and associated chickenpox infection in the UK.

Authors:  Andrew Gustaf Nyman; Helen Wolfenden; Prem Roy; Jill Morris
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 5.  Postpartum group a Streptococcus sepsis and maternal immunology.

Authors:  Katie L Mason; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2011-10-24       Impact factor: 3.886

Review 6.  Necrotizing fasciitis.

Authors:  Rukshini Puvanendran; Jason Chan Meng Huey; Shanker Pasupathy
Journal:  Can Fam Physician       Date:  2009-10       Impact factor: 3.275

7.  Epidemiology of severe Streptococcus pyogenes disease in Europe.

Authors:  Theresa L Lamagni; Jessica Darenberg; Bogdan Luca-Harari; Tuula Siljander; Androulla Efstratiou; Birgitta Henriques-Normark; Jaana Vuopio-Varkila; Anne Bouvet; Roberta Creti; Kim Ekelund; Maria Koliou; Ralf René Reinert; Angeliki Stathi; Lenka Strakova; Vasilica Ungureanu; Claes Schalén; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

8.  An outbreak of invasive group A streptococcal infection among elderly patients receiving care from a district nursing team, October 2013 - May 2014.

Authors:  Oluwakemi Olufon; Nalini Iyanger; Vivien Cleary; Theresa Lamagni
Journal:  J Infect Prev       Date:  2015-03-06

9.  Evaluating Household Transmission of Invasive Group A Streptococcus Disease in the United States Using Population-based Surveillance Data, 2013-2016.

Authors:  Tolulope Adebanjo; Mirasol Apostol; Nisha Alden; Susan Petit; Amy Tunali; Salina Torres; Rosemary Hollick; Austin Bell; Alison Muse; Tasha Poissant; William Schaffner; Chris A Van Beneden
Journal:  Clin Infect Dis       Date:  2020-03-17       Impact factor: 9.079

10.  Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004.

Authors:  Theresa L Lamagni; Shona Neal; Catherine Keshishian; Neelam Alhaddad; Robert George; Georgia Duckworth; Jaana Vuopio-Varkila; Androulla Efstratiou
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.